{"disease":{"id":"eosinophilic-duodenitis","name":"eosinophilic duodenitis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04322604","title":"A Study to Assess AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred to as Eosinophilic Gastroenteritis)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":181,"lead_sponsor_name":"Allakos Inc.","has_results":true},{"nct_id":"NCT04620811","title":"An Extension Study of Lirentelimab in Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred to as Eosinophilic Gastroenteritis)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":159,"lead_sponsor_name":"Allakos Inc.","has_results":true},{"nct_id":"NCT04856891","title":"A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Duodenitis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":94,"lead_sponsor_name":"Allakos Inc.","has_results":true},{"nct_id":"NCT03664960","title":"An Extension Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Duodenitis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":58,"lead_sponsor_name":"Allakos Inc.","has_results":true},{"nct_id":"NCT05831176","title":"A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May Have","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":22,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}